NPSTF yields 5.00% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, NPSTF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NPSTF + PFE for your $10,000?
Nippon Steel Trading Corporation markets and imports/exports steel, industrial supply and infrastructure, textiles, foodstuffs, and other products in Japan and internationally. The company operates through four segments: Steel, Industrial Supply and Infrastructure, Textiles, and Foodstuffs. Its steel products comprise steel sheets, steel pipes and tubes, structural steels, special steel, rods and bars, construction and raw materials, and machinery, as well as other steel, stainless steel, and titanium products. The company also offers industrial supply and infrastructure products, such as machinery and facilities for steel production, general industrial machinery, cast and forged steel products, railroad car components, automotive parts, nonferrous raw materials, nonferrous milled products, and carbon fiber products. In addition, it develops, operates, and sells industrial parks; generates and supplies electric power; and provides water supply and drainage systems. Further, the company offers textile related products and materials. Additionally, it provides foodstuffs that include processed meat products comprising beef, pork, chicken, etc.; processed fishery products, such as shrimp, crab, etc.; agricultural products and processed foods; and other foodstuffs and processed foods. Nippon Steel Trading Corporation was incorporated in 1977 and is headquartered in Tokyo, Japan.
Full NPSTF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.